经桡动脉微创球囊主动脉瓣成形术的安全性、疗效及对衰弱的影响
该前瞻性多中心研究纳入330例在意大利16个中心接受球囊主动脉瓣成形术(BAV)的患者,其中95%经桡动脉入路。结果显示VARC-2大出血为零、小出血仅1.8%,生活质量和衰弱状态在30天后显著改善;BAV后30天达到EFT<3的患者后续TAVI预后较好,而EFT≥3者全因死亡风险最高。
要点
- 经桡动脉微创BAV安全可行,VARC-2大出血为零、小出血1.8%。
- BAV后30天生活质量和衰弱状态(EFT)显著改善。
- BAV后30天EFT≥3者TAVI后全因死亡风险最高(40%)。
核心结论
- 经桡动脉微创BAV安全可行且血管并发症发生率低。
- BAV后30天EFT改善的患者在后续TAVI中预后良好。
研究设计与样本
- 前瞻性研究,纳入在意大利16个中心接受BAV的330例患者。
- 主要终点为VARC-2大出血和小出血的发生。
- 次要终点包括基线和30天时评估的生活质量与衰弱量表及其与全因死亡的关系。
主要发现
- 314例(95%)患者经桡动脉完成BAV。
- 研究人群无VARC-2大出血,发生6例(1.8%)VARC-2小出血。
- BAV后30天生活质量和衰弱状态显著改善。
- 1年时,基线EFT<3或BAV后达到EFT<3并接受TAVI的患者全因死亡发生率相当(15% vs 19%,p=0.58)。
- BAV后30天EFT仍≥3的患者预后最差(全因死亡:40% vs 15%和19%,p=0.006和p=0.05)。
关键数值与推荐
- 主要终点为VARC-2大出血和小出血。
- 衰弱评估采用EFT(essential frailty toolset),阈值3分。
临床怎么用
- 经桡动脉微创BAV可作为TAVI前改善衰弱状态的过渡策略。
- BAV后30天应重新评估EFT,EFT≥3提示后续TAVI预后不佳。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study was designed to: (1) confirm safety and feasibility of mini-invasive radial balloon aortic valvuloplasty (BAV); (2) assess its impact in terms of quality of life and frailty; and (3) evaluate whether changes in frailty after BAV are associated with death in patients undergoing transcatheter aortic valve implantation (TAVI). METHODS: 330 patients undergoing BAV in 16 Italian centres were prospectively included. The primary endpoint was the occurrence of major and minor Valve Academic Research Consortium (VARC)-2 bleeding. Secondary endpoints were scales of quality of life, frailty, evaluated at baseline and 30 days, and their relationship with the occurrence of all-cause death. RESULTS: BAV was performed by radial access in 314 (95%) patients. No VARC-2 major and six (1.8%) VARC-2 minor bleedings occurred in the study population. Quality of life, as well as frailty status, significantly improved 30 days after BAV. At 1 year, patients undergoing TAVI with baseline essential frailty toolset (EFT) <3 or achieving an EFT <3 after BAV had a comparable occurrence of all-cause death (15% vs 19%, p=0.58). On the contrary, patients with EFT ≥3 at 30 days despite BAV showed the worst prognosis (all-cause death: 40% vs 15% and 19%, p=0.006 and p=0.05, respectively). CONCLUSIONS: Mini-invasive radial BAV is safe, feasible and associated with a low rate of vascular complications. Patients improving EFT 30 days after BAV showed a favourable outcome after TAVI. TRIAL REGISTRATION NUMBER: NCT03087552.
引用
- Tumscitz C, Di Cesare A, Balducelli M, et al. Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty. Heart. 2021. PMID: 33627400. doi:10.1136/heartjnl-2020-318548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。